(26) studied the effects of triiodothyronine on MDA-468 breast cancer cells, showing that at physiological doses, the hormone exerts control over the actions of TGFA. Unlike these studies, we show that short treatments with physiological concentrations of T3 do not affect TGFA expression. This evidence concerns the gene TGFA and breast carcinoma.